ClinicalTrials.gov
ClinicalTrials.gov Menu

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study (ASK-500)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00192608
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : June 26, 2009
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Kirby Institute